Do you or your child have ECZEMA?.
Local research study • Investigational topical medication • Compensation for time & travel
The CLEAR-AD1 Study - Now Enrolling
Who can participate? Adults or children (ages 2 or older) who have mild to moderate eczema, also known as atopic dermatitis.
What is the CLEAR-AD1 Study? Millions of kids and adults struggle with eczema and the constant battle against skin irritation. Although there are many medications available, they do not work for everyone and can sometimes cause unwanted side effects. This is why doctors and researchers are working to develop new medications that may better treat eczema in the future. The CLEAR-AD1 Study is evaluating an investigational, steroid-free topical gel for mild to moderate eczema.
How long does the study last? The CLEAR-AD1 Study lasts about 4 months and involves up to 9 visits to your local study doctor’s office. These visits allow your doctor to closely monitor your progress, or that of your child, and discuss your overall experiences.
Where? The study is being offered at select centres throughout Australia.
Is there any cost to me? No, if you or your child qualify and chose to join the study, you will receive all study-related care and study medication at no cost.
Will I be compensated for my participation? Yes, participants will be compensated for their time and travel to attend required study visits.
SEE IF YOU QUALIFY
To see if you or your child might qualify for the CLEAR-AD1 Study, and to get connected with your local study centre to learn more, please take the pre-screening questionnaire below: